by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

OraLabs, Inc. Warning Letter Details

Warning Letter

OraLabs, Inc.

OraLabs, Inc., 18685 East Plaza Drive Parker , CO 80134-9061 United States

Issue DateMarch 11, 2026

FEI Number3001237145

Violations2

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

OraLabs, Inc. FDA Warning Letter, March 11, 2026